Barinthus Biotherapeutics PLC (BRNS)
1.38
+0.06
(+4.55%)
USD |
NASDAQ |
Jun 25, 16:00
1.38
0.00 (0.00%)
After-Hours: 20:00
Barinthus Biotherapeutics Total Liabilities (Quarterly): 27.47M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 27.47M |
| December 31, 2023 | 27.51M |
| September 30, 2023 | 34.37M |
| June 30, 2023 | 28.67M |
| March 31, 2023 | 28.25M |
| December 31, 2022 | 27.00M |
| September 30, 2022 | 31.33M |
| Date | Value |
|---|---|
| June 30, 2022 | 30.29M |
| March 31, 2022 | 32.99M |
| December 31, 2021 | 28.15M |
| September 30, 2021 | 14.10M |
| June 30, 2021 | 9.927M |
| March 31, 2021 | 219.32M |
| December 31, 2020 | 87.58M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
9.927M
Minimum
Jun 2021
219.32M
Maximum
Mar 2021
44.78M
Average
28.46M
Median
Total Liabilities (Quarterly) Benchmarks
| Achilles Therapeutics PLC | 15.39M |
| TC BioPharm (Holdings) PLC | 7.807M |
| Virax Biolabs Group Ltd | 0.919M |
| Adaptimmune Therapeutics PLC | 233.64M |
| Biodexa Pharmaceuticals Plc | 7.470M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 199.48M |
| Shareholders Equity (Quarterly) | 171.83M |